Related Experiment Video
Updated: Jan 4, 2026
03:45
Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
4.1K
Elevated Plasma Histone H4 Levels Are an Important Risk Factor in the Development of Septic Cardiomyopathy
Nian-Fang Lu1, Li Jiang2, Bo Zhu2
1Clinic of Critical Care Medicine, Beijing Electric Power Hospital, Beijing, China
Balkan Medical Journal
|November 2, 2019
Summary
Elevated plasma histone H4 levels are a significant risk factor for septic cardiomyopathy. This finding aids in early diagnosis and management of sepsis-induced heart dysfunction, improving patient outcomes.
Area of Science:
- Cardiology
- Critical Care Medicine
- Biochemistry
Background:
- Septic cardiomyopathy is a critical complication of sepsis, impacting prognosis.
- Early diagnosis and management of septic cardiomyopathy are vital for patient outcomes.
Purpose of the Study:
- To identify the risk factors associated with the development of septic cardiomyopathy.
Main Methods:
- A cross-sectional study involving 93 septic patients in the ICU.
- Measured plasma histone H4, cardiac troponin I, and N-terminal pro-brain natriuretic peptide.
- Utilized echocardiography, logistic regression, and ROC curve analysis to identify risk factors.
Main Results:
- Septic cardiomyopathy patients exhibited higher plasma histone H4, cardiac troponin I, SOFA scores, and vasopressor use.
- Plasma histone H4 levels correlated positively with cardiac troponin I, NT-proBNP, and SOFA scores.
- Elevated plasma histone H4 and vasopressor use were identified as key risk factors for septic cardiomyopathy.
Conclusions:
- Elevated plasma histone H4 levels can predict septic cardiomyopathy in sepsis patients.
- This biomarker may facilitate earlier diagnosis and intervention for septic cardiomyopathy.
Related Concept Videos
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
335
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
335
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
498
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
498
01:23Rheumatic Heart Disease I: Introduction
386
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
386
01:22Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
422
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
422
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
413
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
413
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
740
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
740